Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease

Luisa Weiß(University College Dublin), Patricia B. Maguire(University College Dublin)
Journal of Thrombosis and Haemostasis
October 15, 2024
Cited by 10


Related Papers